Management of Acute Metformin Poisoning
In acute metformin poisoning, immediately discontinue metformin, initiate aggressive supportive care in a hospital setting, and strongly consider prompt hemodialysis for patients with severe lactic acidosis (pH ≤7.0, lactate >20 mmol/L), shock, or failure of standard supportive measures.
Immediate Recognition and Stabilization
Metformin-associated lactic acidosis (MALA) presents with nonspecific symptoms including malaise, myalgias, abdominal pain, respiratory distress, and increased somnolence, though severe cases manifest with hypotension and resistant bradyarrhythmias 1. The diagnosis is confirmed by:
- Elevated blood lactate >5 mmol/L
- Anion gap metabolic acidosis (without ketonuria/ketonemia)
- Increased lactate:pyruvate ratio
- Metformin plasma levels generally >5 mcg/mL 1
Critical pitfall: Do not wait for metformin levels to result—they take days to weeks and should not delay treatment 2. Diagnosis relies on clinical presentation, history of metformin exposure, and routine laboratory findings showing severe lactic acidosis.
Decontamination
For acute ingestion, activated charcoal may be considered if presentation is within 1-2 hours of ingestion 3. However, gastrointestinal decontamination is secondary to immediate supportive care and metabolic correction.
Supportive Care Algorithm
1. Cardiovascular Support
- Aggressive fluid resuscitation for volume depletion
- Vasopressors for shock states
- Continuous hemodynamic monitoring 4, 2
2. Metabolic Correction
- Sodium bicarbonate for severe acidosis, though this alone often fails in severe cases 4
- Maintain body temperature (hypothermia commonly occurs) 5
- Monitor and correct electrolyte abnormalities
3. Respiratory Support
- Intubation and mechanical ventilation for respiratory distress or altered mental status
- Anticipate severe tachypnea as compensatory mechanism
Extracorporeal Treatment: The Definitive Intervention
Hemodialysis is the treatment of choice for severe metformin poisoning 6. The 2015 Extracorporeal Treatments in Poisoning (EXTRIP) Workgroup provides clear criteria:
Absolute Indications for Hemodialysis (all are strong recommendations):
- Lactate >20 mmol/L 6
- pH ≤7.0 6
- Shock 6
- Failure of standard supportive measures 6
- Decreased level of consciousness (moderate recommendation) 6
Hemodialysis Specifications:
- Intermittent hemodialysis is preferred initially over continuous renal replacement therapy (CRRT) 6
- Metformin is dialyzable with clearance up to 170 mL/min under good hemodynamic conditions 1
- Continue until lactate <3 mmol/L AND pH >7.35 6
- CRRT may be used if intermittent hemodialysis unavailable, but may require higher dosing for persistent acidosis 7
- Repeat sessions may be necessary—monitor closely for rebound acidosis 6
Important nuance: Recent data suggests that while CRRT is an alternative, intermittent hemodialysis remains preferred for severe poisoning due to superior clearance rates 7, 6. Standard CRRT dosing may be insufficient in severe cases 7.
Monitoring Parameters
During Treatment:
- Serial arterial blood gases (every 1-2 hours initially)
- Lactate levels (hourly until declining)
- Renal function (creatinine, eGFR)
- Electrolytes (particularly potassium and bicarbonate)
- Core body temperature
- Hemodynamic parameters
Post-Dialysis:
Close monitoring for 6-12 hours after stopping extracorporeal treatment is essential, as rebound acidosis can occur requiring additional dialysis sessions 6.
Prognosis and Outcomes
Mortality in metformin-associated lactic acidosis approaches 30% 6, but early recognition and prompt hemodialysis significantly improve survival 5, 8, 2. Patients meeting EXTRIP criteria who receive timely hemodialysis have approximately 75% survival, with complete recovery possible even in severe cases with cardiac arrest 5, 2.
Key to success: Early involvement of nephrology/dialysis services and poison center consultation (1-800-222-1222 in the US) 9. Do not delay hemodialysis in severe cases—the metabolic derangement is often refractory to bicarbonate therapy alone 4, 6.